Towards the systematic exploration of chemical space.

The discovery of biologically active small molecules is shaped, in large part, by their synthetic (or biosynthetic accessibility). However, chemists' historical exploration of chemical space has been highly uneven and unsystematic. This article describes synthetic strategies that have emerged that may allow chemical space to be explored more systematically. Particular emphasis is placed on approaches that allow the scaffolds of small molecules to be varied combinatorially. In addition, some examples of bioactive small molecules that have been discovered by screening diverse small molecule libraries are highlighted. The authors comment on the likely scope of each of the strategies to deliver skeletally-diverse libraries. In addition, the authors highlight some key challenges for the future: the extension to libraries based on hundreds of distinct scaffolds; and the development of approaches that focus overtly on drug-relevant chemical space.

[1]  B. E. Evans,et al.  Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. , 1988, Journal of Medicinal Chemistry.

[2]  Stefan Wetzel,et al.  Bioactivity-guided mapping and navigation of chemical space. , 2009, Nature chemical biology.

[3]  Hans-Joachim Böhm,et al.  A guide to drug discovery: Hit and lead generation: beyond high-throughput screening , 2003, Nature Reviews Drug Discovery.

[4]  M. Meldal,et al.  Solid-phase synthesis of pyrroloisoquinolines via the intramolecular N-acyliminium Pictet-Spengler reaction. , 2005, Journal of combinatorial chemistry.

[5]  Derek S. Tan,et al.  Solid-phase synthesis and chemical space analysis of a 190-membered alkaloid/terpenoid-like library , 2011, Proceedings of the National Academy of Sciences.

[6]  Richard J. K. Taylor,et al.  Tandem inverse electron demand Diels–Alder, retro-Diels–Alder and intramolecular Diels–Alder sequences: one-pot synthesis of diaza-polycycles , 2007 .

[7]  Adam Nelson,et al.  Synthesis of small molecules with high scaffold diversity: exploitation of metathesis cascades in combination with inter- and intramolecular Diels-Alder reactions. , 2010, Chemistry.

[8]  J. P. Harrity,et al.  Development of a [3+3] cycloaddition strategy toward functionalized piperidines. , 2003, The Journal of organic chemistry.

[9]  Allan M Jordan,et al.  The medicinal chemist's toolbox: an analysis of reactions used in the pursuit of drug candidates. , 2011, Journal of medicinal chemistry.

[10]  C. Humblet,et al.  Escape from flatland: increasing saturation as an approach to improving clinical success. , 2009, Journal of medicinal chemistry.

[11]  Adam Nelson,et al.  Convergent, regiospecific synthesis of quinolines from o-aminophenylboronates. , 2008, Organic letters.

[12]  J. P. Harrity,et al.  Development of a stepwise [3 + 3] annelation to functionalized piperidines. , 2005, Organic letters.

[13]  S. Ōmura,et al.  Generation of anti-trypanosomal agents through concise synthesis and structural diversification of sesquiterpene analogues. , 2011, Journal of the American Chemical Society.

[14]  M. Congreve,et al.  Fragment-based lead discovery , 2004, Nature Reviews Drug Discovery.

[15]  Stefan Wetzel,et al.  Interactive exploration of chemical space with Scaffold Hunter. , 2009, Nature chemical biology.

[16]  Herbert Waldmann,et al.  Compound library development guided by protein structure similarity clustering and natural product structure. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Meldal,et al.  Solid-phase intramolecular N-acyliminium Pictet-Spengler reactions as crossroads to scaffold diversity. , 2004, The Journal of organic chemistry.

[18]  Stuart L. Schreiber,et al.  Skeletally Diverse Small Molecules Using a Build/Couple/Pair Strategy , 2009, Organic letters.

[19]  P. Hajduk,et al.  A decade of fragment-based drug design: strategic advances and lessons learned , 2007, Nature Reviews Drug Discovery.

[20]  Stuart L Schreiber,et al.  A synthesis strategy yielding skeletally diverse small molecules combinatorially. , 2004, Journal of the American Chemical Society.

[21]  György M. Keserü,et al.  The influence of lead discovery strategies on the properties of drug candidates , 2009, Nature Reviews Drug Discovery.

[22]  Andreas Bender,et al.  Anti-MRSA agent discovery using diversity-oriented synthesis. , 2008, Angewandte Chemie.

[23]  T. Ritchie,et al.  The impact of aromatic ring count on compound developability--are too many aromatic rings a liability in drug design? , 2009, Drug discovery today.

[24]  P. Leeson,et al.  The influence of drug-like concepts on decision-making in medicinal chemistry , 2007, Nature Reviews Drug Discovery.

[25]  A. H. Lipkus,et al.  Structural Diversity of Organic Chemistry. a Scaffold Analysis of the Cas Registry , 2022 .

[26]  Adam Nelson,et al.  Synthesis of Natural-Product-Like Molecules with Over Eighty Distinct Scaffolds** , 2008, Angewandte Chemie.

[27]  G. V. Paolini,et al.  Global mapping of pharmacological space , 2006, Nature Biotechnology.

[28]  C. Cordier,et al.  A Fluorous-Tagged “Safety Catch” Linker for Preparing Heterocycles by Ring-Closing Metathesis , 2009, Organic letters.

[29]  N. Isambert,et al.  A cooperative participation of the amido group in the organocatalytic construction of all-carbon quaternary stereocenters by Michael addition with β-ketoamides. , 2011, Organic letters.

[30]  A. Schuffenhauer,et al.  Charting biologically relevant chemical space: a structural classification of natural products (SCONP). , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Stuart L Schreiber,et al.  Towards the optimal screening collection: a synthesis strategy. , 2008, Angewandte Chemie.

[32]  Stuart L Schreiber,et al.  Skeletal diversity via a folding pathway: synthesis of indole alkaloid-like skeletons. , 2005, Organic letters.

[33]  Alan Rolfe,et al.  Formal [4+3] epoxide cascade reaction via a complementary ambiphilic pairing strategy. , 2010, Organic letters.

[34]  Simon J F Macdonald,et al.  Factors determining the selection of organic reactions by medicinal chemists and the use of these reactions in arrays (small focused libraries). , 2010, Angewandte Chemie.

[35]  J. Bajorath,et al.  Docking and scoring in virtual screening for drug discovery: methods and applications , 2004, Nature Reviews Drug Discovery.

[36]  J. Bajorath,et al.  Systematic analysis of public domain compound potency data identifies selective molecular scaffolds across druggable target families. , 2010, Journal of medicinal chemistry.

[37]  Sivaraman Dandapani,et al.  Current strategies for diversity-oriented synthesis. , 2010, Current opinion in chemical biology.

[38]  F. Gao,et al.  Engineering hybrid nanotube wires for high-power biofuel cells. , 2010, Nature communications.

[39]  Jeremy R. Duvall,et al.  An oligomer-based approach to skeletal diversity in small-molecule synthesis. , 2006, Journal of the American Chemical Society.

[40]  S. Warriner,et al.  Synthesis of Skeletally Diverse Alkaloid‐Like Small Molecules , 2011 .

[41]  Adam Nelson,et al.  Natural products as an inspiration in the diversity-oriented synthesis of bioactive compound libraries , 2008, Natural product reports.

[42]  C. Fishwick,et al.  Structure-based discovery of antibacterial drugs , 2010, Nature Reviews Microbiology.

[43]  Stuart L Schreiber,et al.  A planning strategy for diversity-oriented synthesis. , 2004, Angewandte Chemie.

[44]  P. Leeson,et al.  A comparison of physiochemical property profiles of development and marketed oral drugs. , 2003, Journal of medicinal chemistry.

[45]  Didier Rognan,et al.  Assessing the Scaffold Diversity of Screening Libraries , 2006, J. Chem. Inf. Model..

[46]  Stuart L Schreiber,et al.  Generating Diverse Skeletons of Small Molecules Combinatorially , 2003, Science.

[47]  Jie Liang,et al.  Creation and manipulation of common functional groups en route to a skeletally diverse chemical library , 2011, Proceedings of the National Academy of Sciences.

[48]  S. Warriner,et al.  Remarkably slow rotation about a single bond between an sp(3)-hybridised carbon atom and an aromatic ring without ortho substituents. , 2009, Chemistry.

[49]  Herbert Waldmann,et al.  Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Lin-feng Cun,et al.  Organocatalytic direct asymmetric aldol reactions of 3-isothiocyanato oxindoles to ketones: stereocontrolled synthesis of spirooxindoles bearing highly congested contiguous tetrasubstituted stereocenters. , 2011, Organic letters.

[51]  P. Hanson,et al.  A formal [4 + 4] complementary ambiphile pairing reaction: a new cyclization pathway for ortho-quinone methides. , 2010, Organic letters.

[52]  Adam Nelson,et al.  Convergent synthesis of dihydroquinolones from o-aminoarylboronates , 2009 .

[53]  Jérôme Hert,et al.  Quantifying Biogenic Bias in Screening Libraries , 2009, Nature chemical biology.

[54]  A. Hopkins,et al.  Navigating chemical space for biology and medicine , 2004, Nature.

[55]  Richard J. K. Taylor,et al.  Cascade reactions of substituted 1,2,4-triazines: rapid access to nitrogen-containing polycycles. , 2004, Journal of the American Chemical Society.

[56]  Anang A Shelat,et al.  Scaffold composition and biological relevance of screening libraries. , 2007, Nature chemical biology.

[57]  Giovanni Muncipinto,et al.  Short synthesis of skeletally and stereochemically diverse small molecules by coupling petasis condensation reactions to cyclization reactions. , 2006, Angewandte Chemie.

[58]  Herbert Waldmann.  Killing 84 birds with one stone. , 2009, Nature chemical biology.

[59]  M. Meldal,et al.  Solid-phase synthesis of bicyclic dipeptide mimetics by intramolecular cyclization of alcohols, thiols, amines, and amides with N-acyliminium intermediates. , 2005, Organic letters.

[60]  David R Spring,et al.  Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules. , 2010, Nature communications.